Los Angeles Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Los Angeles Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-15,012	Closed	-$302K	–	1518
2018 Q1	$302K	Buy	+15,012	New	+$254K	﹤0.01%	1179
2017 Q3	–	Sell	-29,458	Closed	-$542K	–	1376
2017 Q2	$542K	Buy	+29,458	New	+$584K	﹤0.01%	917
2016 Q1	–	Sell	-37,730	Closed	-$1.14M	–	1218
2015 Q4	$1.14M	Buy	37,730 +26,670	+241%	+$862K	0.01%	639
2015 Q3	$439K	Buy	+11,060	New	+$687K	﹤0.01%	924

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Los Angeles Capital Management's AMAG Position: Q2 2018 in Review

Los Angeles Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 15,012 shares — an estimated $302K sold.

Los Angeles Capital Management first reported a position in AMAG in Q3 2015 and held it in 4 quarters. The position peaked at $1.14M in Q4 2015. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

Los Angeles Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Los Angeles Capital Management sold 15,012 AMAG Pharmaceuticals shares in Q2 2018, an estimated $302K.
Los Angeles Capital Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 4 quarters.
Los Angeles Capital Management's AMAG Pharmaceuticals position peaked at $1.14M in Q4 2015.
173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Los Angeles Capital Management's 13F filing for Q2 2018, filed 31 Jul 2018.